| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Autoantibodies | 100 | + | |
2 | Antibodies, Antinuclear | 76 | + | |
3 | Myelin Basic Protein | 59 | + | |
4 | Mercuric Chloride | 57 | + | |
5 | Antibodies, Monoclonal | 53 | + | |
6 | Interleukin-17 | 44 | + | |
7 | Cytokines | 42 | + | |
8 | Immunoglobulin G | 42 | + | |
9 | Myelin Proteolipid Protein | 41 | + | |
10 | Immunoglobulins, Intravenous | 40 | + | |
11 | Kv1.3 Potassium Channel | 38 | + | |
12 | Hydroxyquinolines | 38 | + | |
13 | Antibodies, Monoclonal, Murine-Derived | 37 | + | |
14 | Receptors, Antigen, T-Cell | 37 | + | |
15 | Myelin-Oligodendrocyte Glycoprotein | 36 | + | |
16 | Peptide Fragments | 36 | + | |
17 | Receptors, IgG | 35 | + | |
18 | Antibodies | 33 | + | |
19 | Receptors, Cholinergic | 33 | + | |
20 | B-Cell Activating Factor | 32 | + | |
21 | Antigen-Antibody Complex | 30 | + | |
22 | Antibodies, Blocking | 29 | + | |
23 | Interleukin-4 | 27 | + | |
24 | Interferon-gamma | 27 | + | |
25 | Antigens, CD4 | 26 | + | |
26 | Histocompatibility Antigens Class II | 26 | + | |
27 | Receptors, Antigen, T-Cell, alpha-beta | 26 | + | |
28 | Peptides | 25 | + | |
29 | CTLA-4 Antigen | 25 | + | |
30 | Interleukin-10 | 25 | + | |
31 | Arrestin | 24 | + | |
32 | DNA | 24 | + | |
33 | Ribonucleoproteins, Small Nuclear | 24 | + | |
34 | Immunoconjugates | 23 | + | |
35 | Antigens, CD28 | 23 | + | |
36 | Myelin Proteins | 23 | + | |
37 | snRNP Core Proteins | 22 | + | |
38 | Nuclear Receptor Subfamily 1, Group F, Member 3 | 22 | + | |
39 | Immunoglobulins | 22 | + | |
40 | Antibodies, Anti-Idiotypic | 21 | + | |
41 | Forkhead Transcription Factors | 21 | + | |
42 | Kv1.1 Potassium Channel | 20 | + | |
43 | Immunoglobulin Fc Fragments | 20 | + | |
44 | Receptors, Antigen, B-Cell | 20 | + | |
45 | Glutamate Decarboxylase | 20 | + | |
46 | Myelin-Associated Glycoprotein | 20 | + | |
47 | Freund's Adjuvant | 20 | + | |
48 | Recombinant Fusion Proteins | 20 | + | |
49 | Oxidoreductases Acting on CH-CH Group Donors | 19 | + | |
50 | Chaperonin 60 | 19 | + | |
51 | Complement System Proteins | 19 | + | |
52 | Immunoglobulin M | 19 | + | |
53 | Eye Proteins | 19 | + | |
54 | Glycoproteins | 19 | + | |
55 | Receptors, Fc | 19 | + | |
56 | CD40 Ligand | 18 | + | |
57 | Cnidarian Venoms | 18 | + | |
58 | Membrane Glycoproteins | 18 | + | |
59 | Receptors, Interleukin-2 | 18 | + | |
60 | Antigens, CD95 | 17 | + | |
61 | Chemokine CXCL6 | 17 | + | |
62 | Collagen Type II | 17 | + | |
63 | Lymphotoxin alpha1, beta2 Heterotrimer | 16 | + | |
64 | Interleukins | 16 | + | |
65 | Antigens, CD86 | 16 | + | |
66 | Kv1.2 Potassium Channel | 16 | + | |
67 | Tumor Necrosis Factor-alpha | 16 | + | |
68 | Interleukin-23 | 16 | + | |
69 | Chemokines | 16 | + | |
70 | B-Cell Activation Factor Receptor | 15 | + | |
71 | Transforming Growth Factor beta | 15 | + | |
72 | Cryoglobulins | 15 | + | |
73 | Receptors, Lysosphingolipid | 15 | + | |
74 | Interleukin-2 | 15 | + | |
75 | Lymphotoxin beta Receptor | 15 | + | |
76 | Immunoglobulin Isotypes | 15 | + | |
77 | Glycolipids | 15 | + | |
78 | Retinol-Binding Proteins | 15 | + | |
79 | NFATC Transcription Factors | 15 | + | |
80 | Interleukin-23 Subunit p19 | 15 | + | |
81 | Complement C1q | 15 | + | |
82 | Receptors, CCR7 | 15 | + | |
83 | Receptors, Chemokine | 15 | + | |
84 | Sialic Acid Binding Ig-like Lectin 2 | 15 | + | |
85 | Interleukin-12 Subunit p35 | 15 | + | |
86 | Receptors, Cell Surface | 14 | + | |
87 | Interleukin-2 Receptor alpha Subunit | 14 | + | |
88 | Vaccines | 14 | + | |
89 | Shaker Superfamily of Potassium Channels | 14 | + | |
90 | Antigens, CD40 | 14 | + | |
91 | Receptors, Calcitriol | 14 | + | |
92 | Myelin P2 Protein | 14 | + | |
93 | Antigens, CD80 | 14 | + | |
94 | Interleukin-6 | 14 | + | |
95 | Receptors, Interleukin-21 | 14 | + | |
96 | Glucocorticoids | 14 | + | |
97 | Receptors, Interleukin-6 | 14 | + | |
98 | Sphingosine | 14 | + | |
99 | Rheumatoid Factor | 14 | + | |
100 | Immunoglobulin Idiotypes | 13 | + | |
101 | Vaccines, DNA | 13 | + | |
102 | Cyclosporine | 13 | + | |
103 | Complement C4 | 13 | + | |
104 | Interleukin-12 | 13 | + | |
105 | Deltaretrovirus Antibodies | 13 | + | |
106 | Chaperonins | 13 | + | |
107 | Receptors, Tumor Necrosis Factor | 13 | + | |
108 | Immunoglobulin Variable Region | 13 | + | |
109 | Ribonucleoprotein, U1 Small Nuclear | 13 | + | |
110 | Cyclophosphamide | 13 | + | |
111 | Receptors, Tumor Necrosis Factor, Member 14 | 13 | + | |
112 | Class Ib Phosphatidylinositol 3-Kinase | 13 | + | |
113 | Receptors, Immunologic | 13 | + | |
114 | Propylene Glycols | 12 | + | |
115 | Complementarity Determining Regions | 12 | + | |
116 | Vitamin D | 12 | + | |
117 | DNA, Single-Stranded | 12 | + | |
118 | Antigens, CD137 | 12 | + | |
119 | Chemokines, CXC | 12 | + | |
120 | Mycophenolic Acid | 12 | + | |
121 | Lymphotoxin-alpha | 12 | + | |
122 | Glucose-6-Phosphate Isomerase | 12 | + | |
123 | Prednisone | 12 | + | |
124 | Receptors, Interleukin-17 | 11 | + | |
125 | Galactosylceramides | 11 | + | |
126 | Receptors, Nerve Growth Factor | 11 | + | |
127 | Complement C3 | 11 | + | |
128 | Janus Kinase 3 | 11 | + | |
129 | T-Box Domain Proteins | 11 | + | |
130 | Galectin 1 | 11 | + | |
131 | STAT4 Transcription Factor | 11 | + | |
132 | Histocompatibility Antigens Class I | 11 | + | |
133 | Tumor Necrosis Factor Ligand Superfamily Member 13 | 11 | + | |
134 | Toll-Like Receptors | 11 | + | |
135 | Transmembrane Activator and CAML Interactor Protein | 11 | + | |
136 | Trinitrobenzenes | 11 | + | |
137 | HLA-DR2 Antigen | 11 | + | |
138 | Interleukin-18 | 10 | + | |
139 | Receptors, Very Late Antigen | 10 | + | |
140 | Cardiolipins | 10 | + | |
141 | Aquaporin 4 | 10 | + | |
142 | Nucleosomes | 10 | + | |
143 | Aequorin | 10 | + | |
144 | Biological Products | 10 | + | |
145 | Prednisolone | 10 | + | |
146 | Peptide Library | 10 | + | |
147 | Indoleamine-Pyrrole 2,3,-Dioxygenase | 10 | + | |
148 | Poly A | 10 | + | |
149 | Antigens, Nuclear | 10 | + | |
150 | gamma-Globulins | 10 | + | |
151 | Lectins, C-Type | 10 | + | |
152 | Adrenal Cortex Hormones | 10 | + | |
153 | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 10 | + | |
154 | Antibodies, Monoclonal, Humanized | 10 | + | |
155 | Fas Ligand Protein | 10 | + | |
156 | Cyclosporins | 10 | + | |
157 | Concanavalin A | 10 | + | |
158 | Complement C3-C5 Convertases | 9 | + | |
159 | beta 2-Glycoprotein I | 9 | + | |
160 | Chemokine CXCL13 | 9 | + | |
161 | Isoxazoles | 9 | + | |
162 | Pertussis Toxin | 9 | + | |
163 | Androstenediol | 9 | + | |
164 | RNA, Small Cytoplasmic | 9 | + | |
165 | Membrane Proteins | 9 | + | |
166 | Hydroxychloroquine | 9 | + | |
167 | Toll-Like Receptor 9 | 9 | + | |
168 | Egg Proteins | 9 | + | |
169 | RNA, Messenger | 9 | + | |
170 | Macrophage Migration-Inhibitory Factors | 9 | + | |
171 | Recombinant Proteins | 9 | + | |
172 | Ovalbumin | 9 | + | |
173 | Ficoll | 9 | + | |
174 | Antibodies, Anticardiolipin | 9 | + | |
175 | Chemokine CXCL10 | 9 | + | |
176 | Receptors, Complement | 9 | + | |
177 | Staphylococcal Protein A | 9 | + | |
178 | Oligodeoxyribonucleotides | 9 | + | |
179 | Chromatin | 8 | + | |
180 | Suppressor Factors, Immunologic | 8 | + | |
181 | Ribonucleoproteins | 8 | + | |
182 | Inducible T-Cell Co-Stimulator Protein | 8 | + | |
183 | Cholera Toxin | 8 | + | |
184 | Immune Sera | 8 | + | |
185 | Receptors, Interferon | 8 | + | |
186 | Pyrimidine Nucleotides | 8 | + | |
187 | Collagen | 8 | + | |
188 | Tumor Necrosis Factors | 8 | + | |
189 | Interferon-beta | 8 | + | |
190 | Methylprednisolone | 8 | + | |
191 | Desmoglein 1 | 8 | + | |
192 | Immunoglobulin Allotypes | 8 | + | |
193 | Azathioprine | 8 | + | |
194 | Janus Kinases | 8 | + | |
195 | Thionucleosides | 8 | + | |
196 | Antibodies, Antineutrophil Cytoplasmic | 8 | + | |
197 | Antigens, CD45 | 8 | + | |
198 | Desmoglein 3 | 8 | + | |
199 | Phytohemagglutinins | 8 | + | |
200 | Receptors, OX40 | 8 | + | |
201 | HLA-DR3 Antigen | 7 | + | |
202 | HLA-DQ Antigens | 7 | + | |
203 | Antigens, CD44 | 7 | + | |
204 | Tumor Necrosis Factor Decoy Receptors | 7 | + | |
205 | Chemokine CCL4 | 7 | + | |
206 | Integrin alpha4 | 7 | + | |
207 | Muramidase | 7 | + | |
208 | Intracellular Signaling Peptides and Proteins | 7 | + | |
209 | Glycoside Hydrolases | 7 | + | |
210 | Integrin alpha4beta1 | 7 | + | |
211 | HLA-DR Antigens | 7 | + | |
212 | Interleukin-12 Subunit p40 | 7 | + | |
213 | Macrophage Inflammatory Proteins | 7 | + | |
214 | Chemokine CCL2 | 7 | + | |
215 | Lipopolysaccharides | 7 | + | |
216 | Methotrexate | 7 | + | |
217 | Myeloblastin | 7 | + | |
218 | Cathepsins | 7 | + | |
219 | Rolipram | 7 | + | |
220 | DNA Primers | 7 | + | |
221 | Vasoactive Intestinal Peptide | 7 | + | |
222 | Toll-Like Receptor 4 | 7 | + | |
223 | Receptors, Aryl Hydrocarbon | 7 | + | |
224 | Lysophospholipids | 7 | + | |
225 | Receptors, Interleukin | 7 | + | |
226 | Proteasome Endopeptidase Complex | 6 | + | |
227 | Steroids | 6 | + | |
228 | RNA, Double-Stranded | 6 | + | |
229 | Receptors, Nicotinic | 6 | + | |
230 | STAT5 Transcription Factor | 6 | + | |
231 | Myosins | 6 | + | |
232 | Aniline Compounds | 6 | + | |
233 | DNA-Binding Proteins | 6 | + | |
234 | Immunoglobulin E | 6 | + | |
235 | Polysaccharides | 6 | + | |
236 | Vaccines, Subunit | 6 | + | |
237 | Complement Inactivator Proteins | 6 | + | |
238 | Nuclear Proteins | 6 | + | |
239 | Integrins | 6 | + | |
240 | Heat-Shock Proteins | 6 | + | |
241 | Protein Subunits | 6 | + | |
242 | Histones | 6 | + | |
243 | Immunotoxins | 6 | + | |
244 | Dehydroepiandrosterone | 6 | + | |
245 | Lymphocyte Function-Associated Antigen-1 | 6 | + | |
246 | Antibodies, Neoplasm | 6 | + | |
247 | Transglutaminases | 6 | + | |
248 | Calcitriol | 6 | + | |
249 | Indazoles | 6 | + | |
250 | Thymosin | 6 | + | |
251 | Fatty Acids, Omega-6 | 6 | + | |
252 | Antibodies, Bispecific | 5 | + | |
253 | Interleukin-15 | 5 | + | |
254 | Bacterial Proteins | 5 | + | |
255 | Antilymphocyte Serum | 5 | + | |
256 | Cell Adhesion Molecules | 5 | + | |
257 | Insulin Antibodies | 5 | + | |
258 | Protein-Tyrosine Kinases | 5 | + | |
259 | 3',5'-Cyclic-AMP Phosphodiesterases | 5 | + | |
260 | Curcumin | 5 | + | |
261 | Receptors, Glucocorticoid | 5 | + | |
262 | Iodide Peroxidase | 5 | + | |
263 | NAD | 5 | + | |
264 | Isoantibodies | 5 | + | |
265 | Oligopeptides | 5 | + | |
266 | Fish Oils | 5 | + | |
267 | DNA, Complementary | 5 | + | |
268 | L-Selectin | 5 | + | |
269 | NF-kappa B | 5 | + | |
270 | Receptors, Tumor Necrosis Factor, Type II | 5 | + | |
271 | Oligonucleotides | 5 | + | |
272 | Matrix Metalloproteinase 9 | 5 | + | |
273 | Thyroglobulin | 5 | + | |
274 | Fatty Acids, Unsaturated | 5 | + | |
275 | Interferon Type I | 5 | + | |
276 | Isoenzymes | 5 | + | |
277 | Intercellular Adhesion Molecule-1 | 5 | + | |
278 | Interleukin 1 Receptor Antagonist Protein | 5 | + | |
279 | Receptors, Thyrotropin | 4 | + | |
280 | Insulin | 4 | + | |
281 | Carrier Proteins | 4 | + | |
282 | Tacrolimus | 4 | + | |
283 | Methimazole | 4 | + | |
284 | TNF-Related Apoptosis-Inducing Ligand | 4 | + | |
285 | Antithyroid Agents | 4 | + | |
286 | Prolactin | 4 | + | |
287 | Vaccines, Synthetic | 4 | + | |
288 | Serum Albumin, Bovine | 4 | + | |
289 | Guanidines | 4 | + | |
290 | Bromocriptine | 4 | + | |
291 | Transcription Factors | 4 | + | |
292 | Cholecalciferol | 4 | + | |
293 | Pyrimidines | 4 | + | |
294 | Interleukin-1 | 4 | + | |
295 | Immunoglobulin Fab Fragments | 4 | + | |
296 | Immunoglobulin A | 4 | + | |
297 | Nitric Oxide Synthase Type II | 4 | + | |
298 | Fatty Acids, Omega-3 | 3 | + | |
299 | Pyrroles | 3 | + | |
300 | Drugs, Chinese Herbal | 3 | + | |
301 | Factor VIII | 3 | + | |
302 | Dexamethasone | 3 | + | |
303 | Interferons | 3 | + | |
304 | Cancer Vaccines | 3 | + | |
305 | Testosterone | 3 | + | |
306 | Proteins | 3 | + | |
307 | Thyroxine | 3 | + | |
308 | Calcium | 3 | + | |
309 | Sirolimus | 2 | + | |
310 | Interferon-alpha | 2 | + | |
311 | Nitric Oxide | 2 | + | |
312 | Plant Extracts | 2 | + | |
313 | Blood Glucose | 1 | + | |